Skip to content

Influence of antacid on cholesterol-lowering effect of rosuvastatin

Influence of antacid on cholesterol-lowering effect of rosuvastatin - Influence of antacid on cholesterol-lowering effect of rosuvastatin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000009514
Enrollment
30
Registered
2012-12-31
Start date
2013-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia

Interventions

Simultaneous administration of antacid and rosuvastatin Separated administration of antacid and rosuvastatin

Sponsors

Shiraiwa Medical Clinic
Lead Sponsor
Department of Metabolic Medicine, Osaka University Graduate School of Medicine
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with hyperlipidemia who require treatment with antacids

Exclusion criteria

Exclusion criteria: renal and/or hepatic disease malignant neoplasm pregnancy drug abuse

Design outcomes

Primary

MeasureTime frame
low-density lipoprotein cholesterol

Countries

Japan

Contacts

Public ContactToshihiko Shiraiwa

Shiraiwa Medical Clinic Shiraiwa Medical Clinic

shiraiwa@shiraiwa-medical-clinic.or.jp0729-71-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026